Markets
Pfizer Stock Receives Upgraded Rating from Wall Street Analysts
American banking news reports that Pfizer's stock has received a positive upgrade, with analysts now recommending a "buy" rating.

© americanbankingnews
AI Summaryacross 1 source
- Pfizer stock has been upgraded from a "hold" to a "buy," indicating a positive outlook.
- Analysts at Winstone Zen are the primary contributors to this upgrade.
- Other analysts, including BMO Capital Markets, also expressed favorable views on Pfizer's prospects.
Coverageacross 1 publisher
How outlets framed itbias spread · click to read
LeftCenterRight
Read the storypick a source →
A balanced askFinz synthesis of 1 source — the facts every source agrees on, with each outlet's framing flagged.
Synthesised from 1 source · askFinz original